Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Nutrition in acute and chronic diseases

Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region

Abstract

Background/objectives

We analyzed the nationwide pediatric inflammatory bowel disease (PIBD) registry (1998–2016), to evaluate the nutritional status at the time of diagnosis.

Subjects/methods

Nine types of nutritional status by the combination of weight-for-length (<2 years)/body mass index (>2 years) and length/height-for-age with three categories (<−2, −2 to 2, and >2 SD) were described. Malnutrition was defined by WHO criteria. Univariate and multivariate regression analysis was used to identify risk factors for malnutrition.

Results

In total, 824 IBD patients (498 Ulcerative colitis (UC); 289 Crohn’s Disease (CD); 37 Indeterminate Colitis (IC); 412 male; the median age 12.5 years) were eligible. The prevalence of eutrophy, wasting/thinness, stunting, overweight, tall stature, concurrent wasting/thinness and stunting, tall stature with overweight, tall stature with wasting/thinness, and short stature with overweight were 67.4%, 14.9%, 6.6%, 3.1%, 3.2%, 3.3%, 1.1%, 0.4%, and 0.1%, respectively. The prevalence of malnutrition was 32.7%, indicating a higher prevalence in CD (p < 0.001). Incidence of overweight was less common in the CD than UC and IC (p < 0.001). Multivariate analysis revealed that age of onset (>10 years), prepubertal stage, severe disease activity, perianal involvement, and high C reactive protein level were independently associated with malnutrition in pediatric IBD.

Conclusion

We showed the frequency of nutritional impairment in PIBD. The percentage of overweight subjects was lower than the other studies. The age of onset, disease activity, CRP level, perianal involvement, and pubertal stage were associated with a higher risk for developing malnutrition. Our results also confirmed that CD patients are particularly vulnerable to nutritional impairment.

Clinical trial number

ClinicalTrials.gov Identifier: NCT04457518.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The patient selection process and the number of participants included.
Fig. 2: Difference in nutritional status of IBD patients at the time of diagnosis according to disease phenotype.

Similar content being viewed by others

Data availability

Raw data the support the findings of this study are available from the corresponding author upon reasonable request. The data that support the findings of this study are available in clinicalTrials.gov at https://clinicaltrials.gov/ct2/show/NCT04457518.

References

  1. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. EJCN. 2000;54:514–21.

    CAS  PubMed  Google Scholar 

  2. Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007;151:523–7.

    Article  PubMed  Google Scholar 

  3. Pituch-Zdanowska A, Banaszkiewicz A, Dziekiewicz M, Lazowsak-Pzzeorek I, Gawronska A, Kowalska-Duplaga K, et al. Overwight and obesity in children with newly diagnosed inflammatory bowel disease. Adv Med Sci. 2016;61:28–31.

    Article  PubMed  Google Scholar 

  4. Chandrakumar A, Wang A, Grover K, El-matary W. Obesity is more common in children newly diagnosed with ulcerative colitis as compered to those with Crohn’s disease. JPGN. 2020;70:593–7.

    CAS  PubMed  Google Scholar 

  5. Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intes Res. 2019;17:9–16.

    Article  Google Scholar 

  6. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–21.

    Article  PubMed  Google Scholar 

  7. Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development and evaluation of a Pediatric ulceratice colitis activity index (PUCAI): a prospective multicenter study. Gastroenterology. 2007;133:423–32.

    Article  PubMed  Google Scholar 

  8. Turner D, Hyams J, Markowitz J, Lere T, Mack DR, Evans J, et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009;15:1218–23.

    Article  PubMed  Google Scholar 

  9. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn’s disease activity index. JPGN. 1991;12:439–47.

    CAS  PubMed  Google Scholar 

  10. Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, De Carpi JM, Bronsky J, et al. Management of paediatric ulcerative colitis, part 1: ambulatory care—an evidence-based guideline from European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. JPGN. 2018;67:257–91.

    PubMed  Google Scholar 

  11. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization; 2011.

  12. World Health Organization, WHO anthro surwey analizer and other tools. https://www.who.int/childgrowth/software/en/. Accessed 25 Mar 2021.

  13. World Health Organization (WHO), United Nations Children’s Fund (UNICEF): Recommendations for data collection, analysis and reporting on anthropometric indicators in children under 5 years old. Geneve: WHO; UNICEF; 2019. https://www.who.int/nutrition/publications/anthropometry-data-quality-report/en/. Accessed 20 Mar 2021.

  14. WHO. Physical status: the use and interpretation of anthropometry Geneva: WHO, 1995. https://www.who.int/childgrowth/publications/physical_status/en/. Accessed 20 Mar 2021.

  15. da Silva Ferreir H. Anthropometric assesment of children’s nutritional status: a new apprach based on an adaptation of waterlow’s classsification. BMC Pediatr. 2020;20:65.

    Article  Google Scholar 

  16. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child 1966;41:613–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Allen LH. Nutritional influences on linear growth: a general review. EJCN. 1994;48:S75–89.

    PubMed  Google Scholar 

  18. Amaro F, Chiarelli F. Growth and puberty in children with inflammatory bowel diseases. Biomedicines. 2020;8:458.

    Article  CAS  PubMed Central  Google Scholar 

  19. Miele R, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, et al. Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology. Hepatol Nutr JPGN. 2018;66:687–708.

    Google Scholar 

  20. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kim S, Koh H. Nutritional aspect of pediatric inflammatory bowel disease: its clincal importance. Korean J Pediatr. 2005;58:363–8.

    Article  CAS  Google Scholar 

  22. El Mouzan MI, Al Edreesi MH, Al-Hussaini AA, Saadah OI, Al Qourain AA, Al, et al. Nutritional status of children with inflammatory bowel disease in Saudi Arabia. World J Gastroenterol. 2016;22:1854–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Vaisman N, Dotan I, Halack A, Niv E. Malabsorption is a major contributor to underweight in Crohn’s disease patients in remission. Nutrition. 2006;22:855–9.

    Article  CAS  PubMed  Google Scholar 

  24. Sawczenko A, Sandhu BK. Presenting features. of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995–1000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lee JJ, Escher JC, Shuman MJ, Forbes PW, Delemarre LC, Harr BW, et al. Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm Bowel Dis. 2010;16:1669–77.

    Article  PubMed  Google Scholar 

  26. Wiskin AE, Wootton SA, Hunt TM, Cornelius VR, Afzal NA, Jackson AA, et al. Body composition in childhood inflammatory bowel disease. Clin Nutr. 2011;30:112–5.

    Article  PubMed  Google Scholar 

  27. Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih M, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006;118:1950–61.

    Article  PubMed  Google Scholar 

  28. Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, et al. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr. 2021;21:35.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Turkey Demographic and Health Survey 2018. http://www.hips.hacettepe.edu.tr/eng/tdhs2018/TDHS_2018_main_report.pdf. Accessed 20 Mar 2021.

  30. Ledder O, Catto-Smith AG, Oliver MR, Alex G, Cameron DJS, Hardikar W. Clinical Patterns and outcome of early-onset inflammtory bowel disease. JPGN. 2014;59:562–4.

    PubMed  Google Scholar 

  31. Robert ME, Tang L, Hao LM, Mugica-Reyes M. Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric popula-tions are limited to children younger than 10 years. Am J Surg Pathol. 2004;28:183–9.

    Article  CAS  PubMed  Google Scholar 

  32. Long MD, Crandall WV, Leibowitz IH, Duffy L, del Rosario F, Kim SC, et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis. 2012;17:2162–8.

    Article  Google Scholar 

  33. Carbonell FRM, Chandan CO. Body mass index at presenttion inflammatory bowel disease in children. PGHN. 2020;23:439–46.

    Google Scholar 

  34. Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB. Gender differences in body compositions deficits at diagnosis in children and adolescents with crohn’s disease. Inflamm Bowel Dis. 2009;13:1121–8.

    Article  Google Scholar 

  35. Bischoff SC, Escher J, Hebuterne X, Stanislaw K, Krznaric Z. et al. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2020;39:632–53.

    Article  PubMed  Google Scholar 

  36. Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, et al. Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of European Society of Pediatric Gastroenterology, Hepatology and Nutrition. JPGN. 2018;66:686–708.

    Google Scholar 

  37. Cucinotta U, Romano C, Dipasquale V. Diet and nutrition in pediatric inflammatory bowel diseases. Nutrients. 2021;13:655.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Santos GM, Silva LR, Santan GO. Nutritional impact of inflammatory bowel diseases on children and adolescents. Rev Paul Pediatr. 2014;32:403–11.

    PubMed  PubMed Central  Google Scholar 

  39. Wine E, Reif SS, Leshinsky-Silver E, Weiss B, Shaoul RR, Shamir R, et al. Pediatric Crohn’s disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics. 2004;114:1281–6.

    Article  PubMed  Google Scholar 

  40. Balestrieri P, Ribolsi M, Guarino MPL, Emerenziani S, Altomare M, Cicala M. Nutritional aspect in inflammatory bowel disease. Nutrients. 2020;12:372.

    Article  CAS  PubMed Central  Google Scholar 

  41. Sulkanen E, Repo M, Huhtala H, Hiltunen P, Kurppa K. Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study. BMC Gastroenterol. 2021;21:364.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Ricciuto A, Mack DR, Huynh HQ, Jacobson K, Otley AR, DeBruyn J, et al. Diagnostic delay is associated with complicated disease and growth impairment in paediatric Crohn’s disease. J Crohn’s Colitis. 2021;15:419–31.

    Article  Google Scholar 

  43. Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, et al. Systematic analysis of the impact of diagnostic delay on bowel damage in paediatric versus adult onset Crohn’s disease. J Crohn’s Colitis. 2019;13:1334–42.

    Article  Google Scholar 

  44. Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Winter HS, Baldassano RN, et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics. 2007;120:e1418–25.

    Article  PubMed  Google Scholar 

  45. Herzog D, Buehr P, Koller R, Rueger V, Heyland K, Nydegger A, et al. Gender differences in paediatric patients of the swiss ınflammatory bowel disease cohort study. PGHN. 2014;17:147–54.

    PubMed  PubMed Central  Google Scholar 

  46. Lee GJ, Kappelman MD, Boyle B, Colletti RB, King E, Pratt JM, et al. Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease. JPGN. 2012;55:701–6.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all our patients and their families for consenting to this study. A sincere thank to James Denison for editing and reviewing this manuscript for English language.

Funding

This research was funded by The Society of Turkish Pediatric Gastroenterology, Hepatology, and Nutrition.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

All authors were provided data input as a part of a project of Nationwide Registry for Pediatric Inflammatory Bowel Disease (NRPIBD). The specific contribution of each author is listed below: Kuloglu Z was responsible for the study concept and design, analysis, intrepretation of data and drafting of the manuscript. Çetin F was the project manager for the project of NRPIBD. Kansu A was responsible for critical review of manuscript. ED was responsible for the statistic analysis. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Zarife Kuloglu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The study protocol was approved by Ege University Ethics Committee (October 12, 2011, No: 11-7/2).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuloglu, Z., Çetin, F., Urgancı, N. et al. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region. Eur J Clin Nutr 76, 1289–1296 (2022). https://doi.org/10.1038/s41430-022-01094-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41430-022-01094-6

This article is cited by

Search

Quick links